Fig. 1From: Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trialModified CONSORT diagram showing patient flow during the studyBack to article page